Emil Kuriakose
CIK 1892413 · Chief Medical Officer · last filed 2026-05-05
Emil Kuriakose is a Chief Medical Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for TERN, was dated May 5, 2026. Across all open-market trades the lifetime net is −$133.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1
2
15
-$133.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Chief Medical Officer | 0 | $52.95 | $0 | -$133.3K | 10 | 2026-05-05 |
| CALA | CHIEF MEDICAL OFFICER | 3,539 | $0.00 | $1 | $0 | 5 | 2023-01-25 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-05 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | −106,515 | -$5.65M | EDGAR |
| 2026-04-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −942 | -$49.7K | EDGAR |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | +56,250 | $0 | EDGAR |
| 2026-01-06 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −1,155 | -$44.6K | EDGAR |
| 2025-10-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −944 | -$7.4K | EDGAR |
| 2025-07-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −853 | -$3.6K | EDGAR |
| 2025-04-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −952 | -$2.4K | EDGAR |
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −4,481 | -$25.6K | EDGAR |
| 2024-12-16 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |